| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000031345 |
| Receipt No. | R000035654 |
| Official scientific title of the study | Randomized controlled trial to evaluate the effect of prophylactic antibiotic administration for patients in totally implantable central venous port |
| Date of disclosure of the study information | 2018/02/17 |
| Last modified on | 2018/02/17 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Randomized controlled trial to evaluate the effect of prophylactic antibiotic administration for patients in totally implantable central venous port | |
| Title of the study (Brief title) | Randomized controlled trial on prophylactic antibiotic administration in totally implantable central venous port | |
| Region |
|
|
| Condition | |||||
| Condition | Case of totally implantable central venous port | ||||
| Classification by specialty |
|
||||
| Classification by malignancy | Malignancy | ||||
| Genomic information | NO | ||||
| Objectives | |
| Narrative objectives1 | To investigate the appropriate use of prophylactic antibiotics administration in totally implantable central venous port |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | Phase II,III |
| Assessment | |
| Primary outcomes | Incidence of surgical site infection within 30 days after totally implantable central venous port |
| Key secondary outcomes | Incidence of totally infectious complications within 30 days after totally implantable central venous port
|
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Administration of 1g of cefazolin before and after surgery | |
| Interventions/Control_2 | Omission of prophylactic antibiotics administration | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Patients with elective totally implantable central venous port
2) No previous chemotherapy or radiation 3) Fulfil all following conditions WBC > 3,000/mm3 Plt > 100,000/mm3 AST < 100 IU/L ALT < 100IU/L T.Bil < 2.0 g/dl Cre < 1.5mg/dl 4) written informed consent |
|||
| Key exclusion criteria | 1) Having active infectious disease
2) With uncontrolled diabetes mellitus 3) With myelosuppression due to immunodeficiency or chemotherapy history 4) With short bowel syndrome 5) With allergy to cephalosporin 6) Patient judged inappropriate by the attending physician |
|||
| Target sample size | 140 | |||
| Research contact person | |
| Name of lead principal investigator | Kazuhisa Uchiyama |
| Organization | Osaka Medical College |
| Division name | General and Gastroenterological Surgery |
| Address | 2-7 Daigaku-machi, Takatsuki city Osaka, Japan |
| TEL | 072-683-1221 |
| uchi@osaka-med.ac.jp | |
| Public contact | |
| Name of contact person | Ryo Tanaka |
| Organization | Osaka Medical College |
| Division name | General and Gastroenterological Surgery |
| Address | 2-7 Daigaku-machi, Takatsuki city Osaka, Japan |
| TEL | 072-683-1221 |
| Homepage URL | |
| sur148@osaka-med.ac.jp | |
| Sponsor | |
| Institute | Osaka medical college, General and Gastroenterological Surgery |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 大阪医科大学 一般・消化器外科 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035654 |